Genital human papillomavirus (HPV) infection is the most common sexually transmitted
disease. Each year 1 million new cases of genital warts are diagnosed, two thirds of which …

Genital warts caused by human papillomavirus infection are encountered commonly in
primary care. Evidence guiding treatment selection is limited, but treatment guidelines …

This review summarizes new treatments from the last seven years employed for the
treatment of genital warts caused by human papillomavirus (HPV). Imquimod 3.75% is a …

Genital warts affect 1% of the sexually active US population and are commonly seen in
primary care. Human papillomavirus types 6 and 11 are responsible for most genital warts …

Objective To summarize and determine the appropriate use for the new and old
management tools for genital warts. Sources of information The following databases were …

External genital warts, also known as condylomata acuminata, are extremely common, with
between 500,000 to one million new cases diagnosed each year in the United States alone …

The treatment of genital warts remains frustrating since it is often painful, expensive, and
unsuccessful. Moreover, little is known about the infectivity and natural history of exophytic …

The increasing incidence of human papillomavirus (HPV) infection and HPV‐associated
conditions such as genital warts in women is a global concern. Genital warts are a clinical …

Wart therapies involve methods of targeted lesion destruction, as well as selective
immunologic modification. While there are several therapeutic options, no treatment has …

Genital warts are one of the most commonly reported sexually transmitted diseases
worldwide. A variety of treatment options are available but few have been assessed in large …